Last update 01 Nov 2024
Rabies Vaccine (Vero Cell)(Changchun Zhuoyi Biological Co. Ltd.)
Last update 01 Nov 2024
Overview
Basic Info
Drug Type Prophylactic vaccine |
Synonyms 冻干人用狂犬病疫苗（Vero细胞）(长春卓谊生物股份有限公司) |
Target- |
Mechanism Immunostimulants |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date CN (23 Nov 2016), |
Regulation- |
Login to view timeline
Related
4
Clinical Trials associated with Rabies Vaccine (Vero Cell)(Changchun Zhuoyi Biological Co. Ltd.)随机、盲法、阳性对照设计评价冻干人用狂犬病疫苗（Vero细胞）接种于10-60岁人群5剂免疫程序的批间一致性和4剂免疫程序（1-1-1-1）的免疫原性和安全性的Ⅲ期临床试验
[Translation] A phase III randomized, blinded, positive-controlled clinical trial to evaluate the batch-to-batch consistency of a 5-dose immunization schedule and the immunogenicity and safety of a 4-dose immunization schedule (1-1-1-1) of freeze-dried human rabies vaccine (Vero cells) in people aged 10-60 years
冻干人用狂犬病疫苗4剂程序接种人群的免疫原性和安全性的随机、盲法、同类疫苗对照的Ⅲ期临床试验
[Translation] A randomized, blinded, similar vaccine-controlled phase III clinical trial on the immunogenicity and safety of a 4-dose regimen of freeze-dried human rabies vaccine
Randomized, Blind, Phase III Clinical Trial to Evaluate the Immunogenicity and Safety of Freeze-dried Human Rabies Vaccine (Vero Cell) Inoculated in 4-dose Program (2-1-1)
100 Clinical Results associated with Rabies Vaccine (Vero Cell)(Changchun Zhuoyi Biological Co. Ltd.)
Login to view more data
100 Translational Medicine associated with Rabies Vaccine (Vero Cell)(Changchun Zhuoyi Biological Co. Ltd.)
Login to view more data
100 Patents (Medical) associated with Rabies Vaccine (Vero Cell)(Changchun Zhuoyi Biological Co. Ltd.)
Login to view more data
100 Deals associated with Rabies Vaccine (Vero Cell)(Changchun Zhuoyi Biological Co. Ltd.)
Login to view more data
External Link
| KEGG | Wiki | ATC | Drug Bank |
|---|---|---|---|
| - | - | - |
R&D Status
Approved
10 top approved records. to view more data
Login
| Indication | Country/Location | Organization | Date |
|---|---|---|---|
| Rabies | CN | 23 Nov 2016 |
Developing
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Human Papillomavirus Infection | Preclinical | CN | 31 Dec 2023 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
NCT05549908 (Pubmed) Manual  | Phase 3 | 1,800 | (tjiggngnse) = The overall incidence of adverse events showed no significant difference between the four-dose test group and the five-dose control group, but was significantly lower in the four-dose test group compared to the four-dose control group bvjuqbvjui (dnebphkuhl ) View more | Positive | 26 Jun 2024 | ||
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free